Pulmonary arterial hypertension (PAH) is caused by a progressive increase in pulmonary vascular resistance (PVR) leading to right ventricular failure and premature death. The condition is diagnosed at right heart catheterisation by physiological variables, namely:
- sustained elevation of mean pulmonary arterial pressure to >25 mmHg at rest or >30 mm Hg with exercise AND
- a mean pulmonary artery occlusion pressure of <15 mmHg
Pulmonary hypertension (PH), conversely, simply represents an elevated mean pulmonary artery pressure and can be a consequence of PAH or other conditions such as left-sided heart disease or hypoxic lung disease. The current classification of conditions leading to pulmonary hypertension is clinically based and is called the Venice classification (shown below).
- Pulmonary arterial hypertension
- Idiopathic PAH
- Familial PAH
- Associated with:
- Connective tissue disease
- Congenital heart disease
- Portal hypertension
- HIV infection
- Drugs and toxins
- Others (thyroid disorders, glycogen storage disease, Gaucher?s disease, hereditary haemorrhagic telangiectasia, haemoglobinopathies, myeloproliferative disorders, splenectomy)
- Other:
- Venous/capillary involvement (pulmonary veno-occlusive disease, pulmonary capillary haemangiomatosis)
- Persistent pulmonary hypertension of the newborn
- PH with left heart disease
- Atrial or ventricular
- Valvular
- PH with lung diseases/ hypoxaemia
- Chronic obstructive pulmonary disease
- Interstitial lung disease
- Sleep disordered breathing
- Alveolar hypoventilation disorders
- Altitude
- Developmental abnormalities
- PH due to chronic thrombotic and/or embolic disease
- Thromboembolic obstruction of proximal pulmonary arteries
- Thromboembolic obstruction of distal pulmonary arteriese
- Non-thrombotic pulmonary embolism (tumour, parasites, foreign material)
- Miscellaneous
- Sarcoidosis, histiocytosis X, lymphangiomatosis, compression of pulmonary vessels (adenopathy, tumour, fibrosing mediastinitis)